Mackinac Laboratories Ltd. — Form D
Mackinac Laboratories Ltd. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-11. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2013-10-11
- Form: D
- Accession: 0001546362-13-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Minimum investment: $25K
- Investors: 4
- Date of first sale: 2013-09-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-204401
Issuer
- Name: Mackinac Laboratories Ltd.
- CIK: 0001546362
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 360 RITCH STREET, SAN FRANCISCO, CA, 94107
- Phone: 415-881-7433
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Daniel G Reed | Director | Portland, OR |
| D. Stewart Butterfield | Director | Portland, OR |
| Prateek G Alsi | Director | Portland, OR |
| Philip G Zahnd | Director | San Francisco, CA |
| Philip G Zahnd | Executive Officer | San Francisco, CA |
| John G Bragg | Director | San Francisco, CA |
| John G Bragg | Executive Officer | San Francisco, CA |
| Neil G Sequeira | Director | San Francisco, CA |
| Ted G Maidenberg | Director | San Francisco, CA |
| Stewart G Butterfield | Director | San Francisco, CA |
| Ted G. Maidenberg | Director | San Francisco, CA |
| John G. Bragg | Director | San Francisco, CA |
| John G. Bragg | Executive Officer | San Francisco, CA |
| Philip G. Zahnd | Director | San Francisco, CA |
| Philip G. Zahnd | Executive Officer | San Francisco, CA |
Other filings by this issuer (8)
More